— Know what they know.
Not Investment Advice

HBRM OTC

Herborium Group, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +9900.0% 1Y: +0.0% 3Y: -33.3% 5Y: -94.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 54 · $1.1M mcap · 8.53B float · 0.0060% daily turnover · Short 20% of daily vol

Income Trends

Revenue
$788K -25.0% ▼
5Y CAGR: -4.5%
Gross Profit
$496K -25.0% ▼
5Y CAGR: -4.9%
Operating Income
-$238K +17.2% ▲
Net Income
-$155K +52.9% ▲
EPS (Diluted)
$0.00 +0.0% ▲
EBITDA
-$238K +17.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1M$1M$1M$1M$788K
YoY Growth+5.8%+7.8%-1.2%-6.1%-25.0%
Cost of Revenue$389K$431K$495K$389K$292K
Gross Profit$662K$702K$624K$662K$496K
Gross Margin63.0%62.0%55.8%63.0%63.0%
R&D Expenses$0$31K$36K$161K$150K
SG&A Expenses$950K$938K$560K$788K$584K
Operating Expenses$950K$969K$596K$950K$734K
Operating Income-$288K-$267K$29K-$288K-$238K
Operating Margin-27.4%-23.6%2.6%-27.4%-30.2%
Interest Expense$41K$0$0$41K$21K
Income Before Tax-$329K-$267K$30K-$329K-$155K
Tax Expense$0$0$0$0$0
Net Income-$329K-$267K$30K-$329K-$155K
Net Margin-31.3%-23.6%2.6%-31.3%-19.6%
EPS (Diluted)$0.00$0.00$0.00$0.00$0.00
EBITDA-$282K-$263K$197K-$288K-$238K
Shares Outstanding8.95B9.69B10.74B10.92B10.92B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms